Related Experiment Videos

The comorbidity of bipolar disorder and cardiovascular diseases from pharmacotherapy perspective

Bjanka Vuksan-Cusa1, Darko Marcinko, Marina Sagud

  • 1University Psychiatric Clinic Rebro, Clinical Hospital Centre Zagreb, 10000 Zagreb, Croatia. bjanka.vuksan@inet.hr

Psychiatria Danubina
|October 2, 2009
PubMed

Insights

Severe mental disorders significantly increase cardiovascular disease (CVD) risk and premature death. Understanding the complex link between mental health and heart conditions is crucial for better patient outcomes.

Area of Science:

  • Cardiology
  • Psychiatry
  • Public Health

Background:

  • Patients with severe mental disorders face higher mortality rates than the general population.
  • Cardiovascular disease (CVD) is the primary cause of premature death in individuals with mental health conditions.
  • The significant comorbidity between cardiac and psychiatric conditions is often overlooked and undertreated.

Purpose of the Study:

  • To investigate the impact of mental health on cardiac disease.
  • To explore the complex underlying mechanisms connecting mental health and cardiovascular conditions.

Main Methods:

  • Literature review and analysis of existing epidemiological data.
  • Exploration of pathophysiological pathways linking mental and cardiac health.
  • Case study analysis of comorbid patients.

Main Results:

  • Mental health disorders are strongly associated with an increased incidence and severity of CVD.
  • Psychological distress and psychiatric symptoms can directly influence cardiovascular risk factors.
  • Shared genetic and environmental factors may contribute to the comorbidity.

Conclusions:

  • The intricate relationship between mental health and cardiac disease necessitates integrated care approaches.
  • Further research into the underlying mechanisms is essential for developing targeted interventions.
  • Addressing mental health is critical for reducing cardiovascular mortality in affected populations.

Related Concept Videos

Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
Bipolar Disorder01:30

Bipolar Disorder

Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers01:27

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in bronchial smooth...
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...